Tag Archives: Myriad

Myriad Genetics’ actions justify a ban on gene patents?

Virus

The following information was provided by Myriad’s General Counsel during his presentation on the subject during a recent BIO IP conference: In order to develop and then ensure the widest possible distribution of the Myriad BRCA diagnostic test, Myriad needed to make the initial discovery, educate the medical community on the values of personalized medicine (the BRCA test), convince insurance companies to cover the test, and educate the patient community.  All of these activities took Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

‘Gene Patents’ Stifle Research?

'Gene Patents' Stifle Research?

The Federal Trade Commission has noted that “concern previously centered on the belief that biotechnology patent protection was too strong” and “would actually obstruct commercialization on new products, thereby hindering follow-on innovation.  This problem has yet to materialize.  The reasons for this are numerous and are often straightforward matters of basic economics. In addition to licensing being widely available, researchers make use of a variety [of] strategies to develop working solutions to the problem of Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Debunking the Myth: Your Genes are Patented

MYTH: YOUR GENES ARE PATENTED. FACTS: IT IS NOT POSSIBLE TO PATENT YOUR GENES The term “gene patent” is a misnomer, because genes as they exist in the body cannot be patented. Because a naturally-occurring gene – even a newly-discovered one – cannot be patented, patents don’t provide ownership rights over our genes, and nobody can infringe a patent by having a certain gene, or by passing it on to their children. If genes aren’t Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,

Media Coverage of BIO’s Intellectual Property Conference in Seattle

Stanford v. Roche: An Academic/Industry Collaboration Gone Wrong A Landmark Case: The Aftermath of Myriad Genetics Ethical Issues: Staying in the Frying Pan and out of the Fire

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Myriad Oral Argument Review and Analysis by Patent Docs

Great comprehensive review of oral arguments at the federal circuit in the Myriad case by Kevin Noonan of Patent Docs.

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,